Literature DB >> 1112830

Metabolism of mevalonate in rats and man not leading to sterols.

A M Fogelman, J Edmond, G Popjåk.   

Abstract

C-5 of mevalonate appears as C0-2 in the breath of rats and men almost immediately after administration either by injection or by mouth. Adult rats exhaled up to 6.5% of a dose of RS-[5-14C]mevalonate (13% of the utilizable R-enantiomer) in the breath in 100 min. The 14-C02 was not derived either from the matabolism of cholesterol biosynthesized from [5-14C]mevalonate or from the metabolism of the unnatural S-enantiomer of mevalonate. The amount of 14-C02 expired in the breath was the same whether the [5-14C]mevalonate was given intravenously or in a drink of water to man. One normocholesterolemic man dissipated 12%, a mildly non-familial hypercholesterolemic man dissipated 10%, and a familial hypercholesterolemic man dissipated 7% of a dose of [5-14C]mevalonate in 24 hours (calculated as a per cent of the R-enantiomer). The observations support the hypothesis of the existence of a metabolic shunt of intermediates of sterol biosynthesis, derived from mevalonate, not leading to sterols.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1112830

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

Review 1.  "As I remember it" research on biosynthesis of fatty acids, triglycerides, squalene, and cholesterol.

Authors:  G Popják
Journal:  J Am Oil Chem Soc       Date:  1977-08       Impact factor: 1.849

Review 2.  The contribution of the cholesterol biosynthetic pathway to intermediary metabolism and cell function.

Authors:  R Fears
Journal:  Biochem J       Date:  1981-10-01       Impact factor: 3.857

3.  The specific molecular architecture of plant 3-hydroxy-3-methylglutaryl-CoA lyase.

Authors:  Andréa Hemmerlin; Alexandre Huchelmann; Denis Tritsch; Hubert Schaller; Thomas J Bach
Journal:  J Biol Chem       Date:  2019-09-12       Impact factor: 5.157

4.  The effect of diabetes on mevalonate metabolism in the rat.

Authors:  M H Wiley; K R Feingold; M M Howton; M D Siperstein
Journal:  Diabetologia       Date:  1982-02       Impact factor: 10.122

5.  Role of the kidneys in the metabolism of plasma mevalonate. Studies in humans and in rhesus monkeys.

Authors:  D J McNamara; E H Ahrens; T S Parker; K Morrissey
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

6.  Multicompartmental analysis of cholesterol metabolism in man. Characterization of the hepatic bile acid and biliary cholesterol precursor sites.

Authors:  C C Schwartz; M Berman; Z R Vlahcevic; L G Halloran; D H Gregory; L Swell
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

7.  Sex difference in human mevalonate metabolism.

Authors:  K R Feingold; M H Wiley; G L Searle; B K Machida; M D Siperstein
Journal:  J Clin Invest       Date:  1980-08       Impact factor: 14.808

8.  3-Hydroxy-3-methylglutaric acid and triton-induced hyperlipidemia in rats.

Authors:  S Y Yousufzai; M Siddiqi
Journal:  Experientia       Date:  1976-09-15

9.  Measurement of cholesterol synthesis in man by isotope kinetics of squalene.

Authors:  G C Liu; E H Ahrens; P H Schreibman; P Samuel; D J McNamara; J R Crouse
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

10.  Hepatic isoprenoid metabolism in a rat model of Smith-Lemli-Opitz Syndrome.

Authors:  R Kennedy Keller; David A Mitchell; Christopher C Goulah; Steven J Fliesler
Journal:  Lipids       Date:  2013-01-30       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.